$FOLD AMICUS THERAPEUTICS, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in AMICUS THERAPEUTICS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in AMICUS THERAPEUTICS, INC. for free.

CIK Number: 0001178879
IRS Number: 200422823
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: FOLD
Company Address: 1 CEDAR BROOK DRIVE CRANBURY 08512
Phone number: 619-537-9849
Former name: AMICUS THERAPEUTICS INC, date of change: 2002-07-29

Amicus Therapeutics, Inc. is a biotechnology company, which is engaged in the discovery, development and commercialization of novel treatments for patients living with rare and orphan diseases. Its product include migalastat HCl, which is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for fabry disease. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.

Market Capitalization: $869.61M
Prev close: $6.02
Average Daily Volume: 3,723,300
Days Low: $5.82
Year Low: $4.41
Year High: $9.83

AMICUS THERAPEUTICS, INC. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Barth JayChief Medical Officer139,288838,514shares bought: 194,692 / shares sold: -117,524 BUYJan 10 201910 days ago
Campbell Bradley LChief Operating Officer252,8781,522,326shares bought: 330,803 / shares sold: -149,021 STRONG BUYJan 10 201910 days ago
Clark David MichaelChief People Officer108,057650,503shares bought: 106,299 / shares sold: 0 STRONG BUYJan 10 201910 days ago
Crowley John FChairman & CEO771,5814,644,918shares bought: 1,234,321 / shares sold: -754,535 BUYJan 17 20193 days ago
Do HungChief Science Officer452,7132,725,332shares bought: 217,794 / shares sold: -394,129 STRONG SELLJan 17 20193 days ago
Prout Samantha WhitemanPrincipal Accounting Officer11,91971,752shares bought: 6,196 / shares sold: 0 BUYJan 10 201910 days ago
Quimi DaphneChief Financial Officer121,803733,254shares bought: 115,066 / shares sold: -28,146 STRONG BUYJan 10 201910 days ago
Rosenberg EllenChief Legal Officer139,525839,941shares bought: 133,126 / shares sold: -5,977 STRONG BUYJan 10 201910 days ago

View all AMICUS THERAPEUTICS, INC. insiders.

AMICUS THERAPEUTICS, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 17 2019FOLDAMICUS THERAPEUTIC ...Do HungChief Science Offic ...Option ExerciseM5.1330,036154,08536,785
Jan 17 2019FOLDAMICUS THERAPEUTIC ...Do HungChief Science Offic ...Option ExerciseM2.944,98814,6650
Jan 17 2019FOLDAMICUS THERAPEUTIC ...Do HungChief Science Offic ...Option ExerciseM5.133,80019,49466,821
Jan 17 2019FOLDAMICUS THERAPEUTIC ...Do HungChief Science Offic ...Option ExerciseM2.944,40012,9364,988
Jan 17 2019FOLDAMICUS THERAPEUTIC ...Do HungChief Science Offic ...SellS12.0536,669441,861438,268474.9 K to 438.3 K (-7.72 %)
Jan 17 2019FOLDAMICUS THERAPEUTIC ...Do HungChief Science Offic ...BuyM5.1330,036154,085474,937444.9 K to 474.9 K (+6.75 %)
Jan 17 2019FOLDAMICUS THERAPEUTIC ...Do HungChief Science Offic ...BuyM2.944,98814,665444,901439.9 K to 444.9 K (+1.13 %)
Jan 17 2019FOLDAMICUS THERAPEUTIC ...Do HungChief Science Offic ...SellS12.0016,600199,200439,913456.5 K to 439.9 K (-3.64 %)
Jan 17 2019FOLDAMICUS THERAPEUTIC ...Do HungChief Science Offic ...BuyM5.133,80019,494456,513452.7 K to 456.5 K (+0.84 %)
Jan 17 2019FOLDAMICUS THERAPEUTIC ...Do HungChief Science Offic ...BuyM2.944,40012,936452,713448.3 K to 452.7 K (+0.98 %)
Jan 17 2019FOLDAMICUS THERAPEUTIC ...Crowley John FChairman & CEOOption ExerciseM10.36103,5001,072,2600
Jan 17 2019FOLDAMICUS THERAPEUTIC ...Crowley John FChairman & CEOSellS11.71103,5001,212,296668,081771.6 K to 668.1 K (-13.41 %)
Jan 17 2019FOLDAMICUS THERAPEUTIC ...Crowley John FChairman & CEOBuyM10.36103,5001,072,260771,581668.1 K to 771.6 K (+15.49 %)
Jan 10 2019FOLDAMICUS THERAPEUTIC ...Prout SamanthaPrincipal Accountin ...Option ExerciseA10.049,50495,4209,504
Jan 10 2019FOLDAMICUS THERAPEUTIC ...Prout SamanthaPrincipal Accountin ...GrantA0.006,196011,9195.7 K to 11.9 K (+108.26 %)

View all AMICUS THERAPEUTICS, INC. insider transactions.